Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study

2023188 citationsJournal Articlegold Open Access

Authors

This study was funded by AstraZeneca UK.

Good health and well-being

Published in: The Lancet Regional Health - Europe

Volume 35, pp. 100747-100747

Field-Weighted Citation Impact: 36.41